A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine

Haemophilus influenzae

Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b The Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib Vaccine Study to Assess the Safety of a New GSK Biologicals’ GSK2231395A Candidate Vaccine Study to Eliminate Hib Carriage in Rural Alaska Native Villages Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults Nontypeable H. Influenzae in Healthy Adults A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b